VEGF

Correlation between chromosome 1p/19q status and VEGF mRNA expression in gliomas

B. Yang, Hao, X. Q., Zeng, X. W., Ji, T. L., Pan, S., Feng, Y. G., Yang, B., Hao, X. Q., Zeng, X. W., Ji, T. L., Pan, S., Feng, Y. G., Yang, B., Hao, X. Q., Zeng, X. W., Ji, T. L., Pan, S., and Feng, Y. G., Correlation between chromosome 1p/19q status and VEGF mRNA expression in gliomas, vol. 15, p. -, 2016.

The chromosome 1p/19q deletion has been reported as a good prognosis marker for gliomas. However, the detection of 1p/19q status alone in glioma patients is not sufficient. The identification of a combination of molecular factors could effectively enhance the prediction accuracy. Thus far, the potential correlation between the 1p/19q status and vascular endothelial growth factor (VEGF) expression has not been elucidated. The level of VEGF mRNA expression in the tumor and the adjacent normal tissues was determined by real-time polymerase chain reaction.

Role of VEGF gene polymorphisms in the clinical outcome of non-small cell lung cancer

N. Chen, Ma, C. N., Zhao, M., and Zhang, Y. J., Role of VEGF gene polymorphisms in the clinical outcome of non-small cell lung cancer, vol. 14, pp. 16006-16011, 2015.

This report details a study conducted to assess the role of VEGF gene polymorphisms in the prognosis of advanced non-small cell lung carcinoma (NSCLC). Samples obtained from 210 advanced NSCLC patients admitted at the Huaihe Hospital of Henan University between January 2010 and December 2011 were recruited for this study. The VEGF -2578C/A (rs699947), +936C/T (rs3025039), and -634G/C (rs2010963) genotypes were analyzed by polymerase chain reaction-restriction fragment length polymorphism.

Influence of vascular endothelial growth factor and alpha-fetoprotein on hepatocellular carcinoma

E. Y. Yvamoto, Ferreira, R. F., Nogueira, V., Pinhel, M. A. S., Tenani, G. D., Andrade, J. G. S. C., Baitello, M. E. L., Gregório, M. L., Fucuta, P. S., Silva, R. F., Souza, D. R. S., and Silva, R. C. M. A., Influence of vascular endothelial growth factor and alpha-fetoprotein on hepatocellular carcinoma, vol. 14, pp. 17453-17462, 2015.

We evaluated the influence of the vascular endothelial growth factor (VEGF) -C936T polymorphism on prognosis of hepatocellular carcinoma (HCC), cirrhosis, and hepatitis C virus (HCV) infection. Serum VEGF and alpha-fetoprotein (AFP) levels were determined and used to characterize sensitivity and specificity. A total of 285 subjects were studied: 68 HCC, 118 cirrhosis, 43 HCV, and 56 healthy controls.

Association between angiogenic growth factor genetic polymorphisms and the risk of osteosarcoma

H. F. Zhang, Yan, J. P., Zhuang, Y. S., and Han, G. Q., Association between angiogenic growth factor genetic polymorphisms and the risk of osteosarcoma, vol. 14, pp. 10524-10529, 2015.

The aim of this study was to assess the role of the VEGF -2578C/A, +936C/T, and -460T/C gene polymorphisms in the development of osteosarcoma. A total of 182 patients with osteosarcoma and 182 age- and gender-matched healthy controls were enrolled into our study during January 2011 and December 2013. Genotype frequencies of the VEGF -2578C/A and -460T/C alleles in controls were found to be within the parameters of Hardy-Weinberg equilibrium, but the genotype frequencies of +936C/T alleles were not.

Subscribe to VEGF